Pam2 lipopeptides enhance the immunosuppressive activity of monocytic myeloid-derived suppressor cells by STAT3 signal in chronic inflammation

Chronic inflammation develops when the immune system is unable to clear a persistent insult. Unresolved chronic inflammation leads to immunosuppression to maintain the internal homeostatic conditions, which is mediated primarily by myeloid-derived suppressor cells (MDSCs). Toll-like receptors 2 (TLR2) has an important role in chronic inflammation and can be activated by a vast number and diversity of TLR2 ligands, for example Pam2CSK4. However, the regulatory effect of TLR2 signaling on MDSCs in chronic inflammation remains controversial. This study demonstrated that heat-killed Mycobacterium bovis BCG-induced pathology-free chronic inflammation triggered suppressive monocytic MDSCs (M-MDSCs) that expressed TLR2. Activation of TLR2 signaling by Pam2CSK4 treatment enhanced immunosuppression of M-MDSCs by upregulating inducible nitric oxide synthase (iNOS) activity and nitric oxide (NO) production partly through signal transducer and activator of transcription 3 (STAT3) activation. Thus, TLR2 has a fundamental role in promoting the MDSC-mediated immunosuppressive environment during chronic inflammation and might represent a potentially therapeutic target in chronic inflammation disease.

[1]  Jing-jing Zhao,et al.  USP12 promotes CD4+ T cell responses through deubiquitinating and stabilizing BCL10 , 2021, Cell Death & Differentiation.

[2]  Hongyan Yuan,et al.  Dual roles of myeloid-derived suppressor cells induced by Toll-like receptor signaling in cancer , 2020, Oncology letters.

[3]  L. Conti,et al.  Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota , 2020, International journal of molecular sciences.

[4]  G. Sung,et al.  STAT3 Differentially Regulates TLR4-Mediated Inflammatory Responses in Early or Late Phases , 2020, International journal of molecular sciences.

[5]  Jiying Chen,et al.  CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. , 2019, Biochemical and biophysical research communications.

[6]  Y. Chu,et al.  TLR1/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage. , 2019, Molecular immunology.

[7]  O. Tirosh,et al.  iNOS as a metabolic enzyme under stress conditions. , 2019, Free radical biology & medicine.

[8]  Y. Ostapchuk,et al.  Chronic Inflammation Contributes to Tumor Growth: Possible Role of l-Selectin-Expressing Myeloid-Derived Suppressor Cells (MDSCs) , 2018, Inflammation.

[9]  M. Baniyash,et al.  Plasticity and biological diversity of myeloid derived suppressor cells. , 2018, Current opinion in immunology.

[10]  Min Liu,et al.  IFN‐&ggr; decreased the suppressive function of CD33+HLA‐DRlow myeloid cells through down‐regulation of PD‐1/PD‐L2 signaling pathway , 2018, Molecular immunology.

[11]  A. Dorhoi,et al.  Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections , 2018, Front. Immunol..

[12]  Jian Zhao,et al.  Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients , 2017, Oncotarget.

[13]  James A. Hutchinson,et al.  Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function. , 2017, Blood advances.

[14]  J. Niu,et al.  Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling , 2017, PloS one.

[15]  A. Eid,et al.  Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways , 2016, Scientific Reports.

[16]  D. Gabrilovich,et al.  Transcriptional regulation of myeloid‐derived suppressor cells , 2015, Journal of leukocyte biology.

[17]  W. Gong,et al.  Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune‐evasion via the Toll‐like receptor 2 pathway , 2015, Immunology.

[18]  Y. Meirow,et al.  Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate , 2015, Front. Immunol..

[19]  Yimin Fang,et al.  IFN-γ differentially regulates subsets of Gr-1(+)CD11b(+) myeloid cells in chronic inflammation. , 2015, Molecular immunology.

[20]  M. Teixeira,et al.  iNOS Activity Modulates Inflammation, Angiogenesis, and Tissue Fibrosis in Polyether-Polyurethane Synthetic Implants , 2015, Mediators of inflammation.

[21]  H. Shime,et al.  Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling. , 2015, Biochemical and biophysical research communications.

[22]  Xiao-hou Wu,et al.  Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3 , 2015, Medical Oncology.

[23]  Zhenwei Yao,et al.  Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice. , 2014, Clinical immunology.

[24]  Minho Chae,et al.  Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid‐derived suppressor cells via TLR2‐dependent STAT3 activation , 2014, European journal of immunology.

[25]  A. Ray,et al.  Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation , 2013, Front. Cell. Infect. Microbiol..

[26]  S. Singhal,et al.  Myeloid derived suppressor cells , 2013, Oncoimmunology.

[27]  M. Sade-Feldman,et al.  Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. , 2013, Immunity.

[28]  Weijing Zhang,et al.  Murine Myeloid Dendritic Cells That Phagocytose Apoptotic T Cells Inhibit the Immune Response via NO , 2012, PloS one.

[29]  G. Konopka,et al.  STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation , 2012, The Journal of Neuroscience.

[30]  S. Su,et al.  The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases. , 2011, International immunopharmacology.

[31]  S. Wenzel,et al.  TLR4/MyD88-Induced CD11b+Gr-1intF4/80+ Non-Migratory Myeloid Cells Suppress Th2 Effector Function in the Lung , 2010, Mucosal Immunology.

[32]  Lian-tang Wang,et al.  Endogenous toll-like receptor ligands and their biological significance , 2010, Journal of cellular and molecular medicine.

[33]  B. Chauffert,et al.  Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.

[34]  L. Moldawer,et al.  MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis , 2007, The Journal of experimental medicine.

[35]  H. Mühl,et al.  The Interleukin-22/STAT3 Pathway Potentiates Expression of Inducible Nitric-oxide Synthase in Human Colon Carcinoma Cells* , 2007, Journal of Biological Chemistry.

[36]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[37]  M. Baniyash.  Chronic inflammation, immunosuppression and cancer: new insights and outlook. , 2006, Seminars in cancer biology.

[38]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[39]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.